Product
Levodopa/Carbidopa
1 clinical trial
1 indication
Indication
Parkinson's DiseaseClinical trial
A Randomized, Double-Blind, Double-Dummy, Active-Controlled Study Comparing the Efficacy, Safety and Tolerability of ABBV-951 to Oral Carbidopa/Levodopa in Advanced Parkinson's Disease PatientsStatus: Completed, Estimated PCD: 2021-09-29